
Altos Labs
Top 100
Illustrative curve — no price history on file for this company.
Funding
Raised a $3B round on Jan 19, 2022, bringing the total raised amount to $3B.
Hiring Signal
Based on public job postings · updated monthly
Latest news
Public companies tied to Altos Labs
About Altos Labs
Altos Labs is a biotechnology company pioneering cellular rejuvenation programming, using partial epigenetic reprogramming with Yamanaka factors to restore cell health and resilience and reverse disease, injury, and the disabilities of aging. It launched publicly in January 2022 with about $3 billion in initial funding, one of the largest biotech launches ever, backed by Jeff Bezos and Yuri Milner and led by CEO Hal Barron, with Nobel laureate Shinya Yamanaka as senior scientific advisor. The company remains privately held and its valuation is not officially disclosed; secondary-market estimates put it around $6 billion in early 2026.










